SMTL ID : 6o3b.1 (1 other biounit)

Crystal structure of Frizzled 7 CRD in complex with F6 Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-1-mer

Ligands

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 9 residues within 4Å: Chain A: S.162, S.176, T.178 Chain B: L.148, F.173, V.176, S.184, L.185, S.186 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.176 GOL.2: 4 residues within 4Å: Chain B: A.165, L.166, T.167, S.168 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:T.167, B:T.167, B:S.168, B:S.168 GOL.4: 5 residues within 4Å: Chain C: P.16, L.17, Y.48, K.52, R.60 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:P.16, C:Y.48, C:K.52, C:R.60, C:R.60

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 1 residues within 4Å: Chain C: N.24 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Raman, S. et al., Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies. Proc. Natl. Acad. Sci. U.S.A. (2019)

Release Date

2019-04-03

Peptides

Antibody Fab F6, Light chain: A
Antibody Fab F6, Heavy chain: B
Frizzled-7: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Antibody Fab F6, Light chain

Antibody Fab F6, Heavy chain

Frizzled-7

Related Entries With Identical Sequence